Evidence map›Paper›PMID 29317817›Full record

ArticleInternational journal of nanomedicine2018

Antibacterial activity of trimetal (CuZnFe) oxide nanoparticles.

Khalid E Alzahrani, Abdurahman A Niazy, Abdullah M Alswieleh, Rizwan Wahab, Ahmed M El-Toni, Hamdan S Alghamdi

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Green synthesis ofRSC advances · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. The role of nanocomposites against biofilm infections in humans.Frontiers in cellular and infection microbiology · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khalid E AlzahraniDepartment of Physics and Astronomy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Abdurahman A NiazyPrince Naif Health Research Center, Molecular and Cell Biology Laboratory, College of Dentistry, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Abdullah M AlswielehDepartment of Chemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Rizwan WahabDepartment of Zoology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Ahmed M El-ToniKing Abdullah Institute for Nanotechnology, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Hamdan S AlghamdiPrince Naif Health Research Center, Molecular and Cell Biology Laboratory, College of Dentistry, King Saud University, Riyadh, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe increasing resistance of pathogenic bacteria to antibiotics is a challenging worldwide health problem that has led to the search for new and more efficient antibacterial agents. Nanotechnology has proven to be an effective tool for the fight against bacteria.

methodsIn this paper, we present the synthesis and traits of trimetal (CuZnFe) oxide nanoparticles (NPs) using X-ray diffraction, high-resolution transmission electron microscopy, and energy dispersive x-ray spectroscopy. We evaluated the antibacterial activity of these NPs against gram-negative

resultsOur study showed that the antibacterial activity of the trimetal oxide NPs was greater against

conclusionThe combination of three metal oxide NPs (ZnO, CuO, and Fe

Indexed as

Anti-Bacterial AgentsCopperDrug Evaluation, PreclinicalDrug StabilityEnterococcus faecalisEscherichia coliFerric CompoundsMetal NanoparticlesMicroscopy, Electron, TransmissionNanotechnologyX-Ray DiffractionZinc OxideAnti-Bacterial AgentsCoppercupric oxideFerric Compoundsferric oxideZinc Oxideantibacterial agentsEnterococcus faecalisEscherichia colinanoparticlesnanotechnologytrimetal nanoparticles

Identifiers

PMID29317817
PMCPMC5743187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.